2-[[[4-(4-chlorophenyl)-5-propan-2-yl-1,3-thiazol-2-yl]amino]methyl]-3-(3-fluorophenyl)propanoic acid
C22H22ClFN2O2S — CID 156849678
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[[4-(4-chlorophenyl)-5-propan-2-yl-1,3-thiazol-2-yl]amino]methyl]-3-(3-fluorophenyl)propanoic acid
2-[[[4-(4-chlorophenyl)-5-propan-2-yl-1,3-thiazol-2-yl]amino]methyl]-3-(3-fluorophenyl)propanoic acid (PubChem CID 156849678) has the molecular formula C22H22ClFN2O2S and a molecular weight of 432.95 g/mol. Its IUPAC name is 2-[[[4-(4-chlorophenyl)-5-propan-2-yl-1,3-thiazol-2-yl]amino]methyl]-3-(3-fluorophenyl)propanoic acid.
Molecular Properties
| Compound Name | 2-[[[4-(4-chlorophenyl)-5-propan-2-yl-1,3-thiazol-2-yl]amino]methyl]-3-(3-fluorophenyl)propanoic acid |
|---|---|
| PubChem CID | 156849678 |
| Molecular Formula | C22H22ClFN2O2S |
| Molecular Weight | 432.95 g/mol |
| Exact Mass | 432.11 |
| IUPAC Name | 2-[[[4-(4-chlorophenyl)-5-propan-2-yl-1,3-thiazol-2-yl]amino]methyl]-3-(3-fluorophenyl)propanoic acid |
| SMILES | CC(C)c1sc(NCC(Cc2cccc(F)c2)C(=O)O)nc1-c1ccc(Cl)cc1 |
| InChI | InChI=1S/C22H22ClFN2O2S/c1-13(2)20-19(15-6-8-17(23)9-7-15)26-22(29-20)25-12-16(21(27)28)10-14-4-3-5-18(24)11-14/h3-9,11,13,16H,10,12H2,1-2H3,(H,25,26)(H,27,28) |
| InChIKey | SNFMNKKYRMWBFZ-UHFFFAOYSA-N |
| XLogP | 6.08 |
| TPSA | 62.22 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.95 |
| LogP ≤ 5 | 6.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156849678 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.